Strategic Partners A/SCHIX:STRAPC 30 PS Ratio is 1,117.82 as of Jun. 29, 2026, which is 1222% above its 10-year median of 84.55. GuruFocus rates CHIX:STRAPC with a GF Score™ of 30/100. Among 935 Biotechnology companies, Strategic Partners A/S ranks worse than 83.21% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Strategic Partners A/S's share price is kr8425.00.
Strategic Partners A/S's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was kr7.54. Hence, Strategic Partners A/S's PS Ratio for today is 1,117.82.
Good Sign:
Strategic Partners A/S stock PS Ratio (=80.2) is close to 1-year low of 76.39.
The historical rank and industry rank for Strategic Partners A/S's PS Ratio or its related term are showing as below:
CHIX:STRAPc'
s PS Ratio Range Over the Past 10 Years
Min: 76.39 Med: 84.55 Max: 100.31
Current: 78.28
During the past 12 years, Strategic Partners A/S's highest PS Ratio was 100.31. The lowest was 76.39. And the median was 84.55.
CHIX:STRAPc's PS Ratio is ranked worse than 83.21% of 935
companies
in the Biotechnology industry
Industry Median: 9.29
vs CHIX:STRAPc: 78.28
Strategic Partners A/S (CHIX:STRAPc) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:STRAPC vs VRTX, REGN, ALNY: PS Ratio Comparison
For the Biotechnology subindustry, Strategic Partners A/S's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Strategic Partners A/S PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Strategic Partners A/S's PS Ratio distribution charts can be found below:
* The bar in red indicates where Strategic Partners A/S's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Strategic Partners A/S's Share Price of today is kr8425.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Strategic Partners A/S's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was kr7.54.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Strategic Partners A/S (CHIX:STRAPC) has a PS Ratio of 1,117.82 as of Jun. 29, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Strategic Partners A/S and its competitors. This is 1222% above median its historical median of 84.55. Over the past decade, Strategic Partners A/S's PS Ratio has ranged from 76.39 to 100.31. According to the industry distribution chart, Strategic Partners A/S ranks #778 out of 935 companies in the Biotechnology industry, placing it in the top 83.2%.
Is Strategic Partners A/S's PS Ratio too high?
Strategic Partners A/S's current PS Ratio of 1,117.82 is 1222% above median its 10-year median of 84.55. Over the past 10 years, this metric has ranged from a low of 76.39 to a high of 100.31. The Biotechnology industry median PS Ratio is 9.29. Strategic Partners A/S's value of 1,117.82 is 11932.5% above this industry median. Based on the distribution chart, Strategic Partners A/S ranks #778 out of 935 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Strategic Partners A/S has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Strategic Partners A/S's PS Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Strategic Partners A/S ranks #778 out of 935 companies for PS Ratio. This places Strategic Partners A/S in the lower half of its industry. The industry median PS Ratio is 9.29. Strategic Partners A/S's value of 1,117.82 is 11932.5% above this benchmark. Historically, Strategic Partners A/S's own PS Ratio has ranged from 76.39 to 100.31 over the past decade. While the company's 10-year median is 84.55 vs. the industry median of 9.29, Strategic Partners A/S has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.29, based on 935 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Strategic Partners A/S's current PS Ratio of 1,117.82 is 11932.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Strategic Partners A/S and its competitors. For the Biotechnology industry, the median PS Ratio is 9.29 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Strategic Partners A/S's current PS Ratio is 1,117.82, which is 1222% above median its own 10-year median of 84.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Strategic Partners A/S stock overvalued right now?
Strategic Partners A/S (CHIX:STRAPC) has a current PS Ratio of 1,117.82. The current PS Ratio is 1,117.82, which is 1222% above median its 10-year median of 84.55 and 11932.5% above the Biotechnology industry median of 9.29. Strategic Partners A/S's overall GF Score™ is 30/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Strategic Partners A/S (CHIX:STRAPC), the current PS Ratio is 1,117.82 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Strategic Partners A/S enters into strategic partnerships with companies with potential, where the company can take an active ownership and create value through its competencies. Additionally, the company takes part in other equity investments and properties, etc., to generate returns.
30GF Score
Get the complete analysis for CHIX:STRAPC
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:STRAPC has been successfully added to your 
